![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/02 | |
A61K 47/06 | |||
A61K 47/10 | |||
A61K 47/12 | |||
A61K 9/08 | |||
A61M 11/00 | |||
A61M 15/00 | |||
A61K 31/46 | |||
A61K 9/00 |
(11) | Number of the document | 2897589 |
(13) | Kind of document | T |
(96) | European patent application number | 14809570.6 |
Date of filing the European patent application | 2014-11-21 | |
(97) | Date of publication of the European application | 2015-07-29 |
(45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/066840 |
Date | 2014-11-21 |
(87) | Number | WO 2015/077574 |
Date | 2015-05-28 |
(30) | Number | Date | Country code |
201361907778 P | 2013-11-22 | US |
(72) |
DALVI, Mukul, US
WU, Libo, US
|
(73) |
Teva Branded Pharmaceutical Products R & D, Inc.,
41 Moores Road, Frazer, PA 19355,
US
|
(54) | AN INHALABLE MEDICAMENT |
AN INHALABLE MEDICAMENT |